Gül Alço

Gül Alço

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
ŞIŞefik İğDem
Şefik İğDem
Gül AlçoGül Alço
Gül Alço
TETülay Ercan
Tülay Ercan
MBMetin Barlan
Metin Barlan
KGKürşat Ganiyusufoğlu
Kürşat Ganiyusufoğlu
SOSait Okkan
Sait Okkan

1 December 2010 in British Journal of Radiology
Verified
Journal Article
Closed access
Gül AlçoGül Alço
Gül Alço
SIS I Iğdem
S I Iğdem
TET Ercan
T Ercan
MDM Dinçer
M Dinçer
RŞR Şentürk
R Şentürk
SOS Okkan
S Okkan
The aim of this study is to evaluate the coverage of axillary nodal volumes with high tangent fields (HTF) in breast radiotherapy and to determine the utility of customised blocking. The treatment plans of 30 consecutive patients with early breast cancer were evaluated. The prescription dose was 50 Gy to the whole breast. Axillary level I-II lymph node volumes were delineated and the cranial border of the tangential fields was set just below the humeral head to create HTF. Dose-volume histograms (DVH) were used to calculate the doses received by axillary nodal volumes. In a second planning set, HTF were modified with multileaf collimators (MLC-HTF) to obtain an adequate dose coverage of axillary nodes. The mean doses of the axillary nodes, the ipsilateral lung and heart were compared between the two plans (HTF vs MLC-HTF) using a paired sample t-test. The doses received by 95% of the breast volumes were not significantly different for the two plans. The doses received by 95% of the level I and II axillary volumes were 16.79 Gy and 11.59 Gy, respectively, for HTF, increasing to 47.2 Gy and 45.03 Gy, respectively, for MLC-HTF. Mean lung doses and per cent volume of the ipsilateral lung receiving 20 Gy (V20) were also increased from 6.47 Gy and 10.47%, respectively, for HTF, to 9.56 Gy and 16.77%, respectively, for MLC-HTF. Our results suggest that HTF do not adequately cover the level I and II axillary lymph node regions. Modification of HTF with MLC is necessary to obtain an adequate coverage of axillary levels without compromising healthy tissue in the majority of the patients.

10 December 2019 in European Radiology
Verified
Journal Article
Closed access
PDF file
FÇFiliz Çelebi
Filiz Çelebi
FAFiliz Agacayak
Filiz Agacayak
AOAlper Ozturk
Alper Ozturk
SISerkan Ilgun
Serkan Ilgun
MUMuhammed Ucuncu
Muhammed Ucuncu
VÖVahit Özmen
Vahit Özmen

16 May 2018 in European Journal of Breast Health
Verified
Journal Article
Closed access
FIFiliz İzCi
Filiz İzCi
DSDauren Sarsanov
Dauren Sarsanov
ZEZeynep Iyigun Erdogan
Zeynep Iyigun Erdogan
AIAhmet Serkan Ilgun
Ahmet Serkan Ilgun
ECEsra Celebi
Esra Celebi
VOVahit Ozmen
Vahit Ozmen
The aim of this study was to investigate the impacts of personality traits, anxiety, depression and hopelessness levels on quality of life in the patients with breast cancer. The study was performed on 90 patients diagnosed with breast cancer and 90 healthy women. Sociodemographic and Clinical Data Collection Form designed by us, Beck Hopelessness Scale (BHS), Beck Anxiety Scale (BAS), Beck Depression Scale (BDS), Eysenck Personality Inventory (EPI) and Quality of Life Scale-Short Form (SF-36) were administered to patients and to control group. The patients with breast cancer were found to indicate higher levels of anxiety and depression, lower levels of quality of life, and higher scores of personality inventory subscales as compared to the healthy control group. In the patient group, it was identified that the quality of life subscale scores were found to be negatively correlated with anxiety, depression, hopelessness and neurotic personality scores; there was a positive correlation between neurotic personality scores and depression, anxiety and hopelessness scores. It can be concluded that the breast cancer patients with extraversion personality traits have lower levels of anxiety and depression, keeping their quality of life better, whereas the patients with higher neuroticism scores may have more impaired quality of life. Therefore, the psychiatric evaluation of the breast cancer patients during and after the treatment cannot be ruled out.

1 November 2009 in British Journal of Radiology
Verified
Journal Article
Closed access
ŞIŞ İğdem
Ş İğdem
HAH Akpinar
H Akpinar
Gül AlçoGül Alço
Gül Alço
FAF Ağaçayak
F Ağaçayak
STS Turkan
S Turkan
SOS Okkan
S Okkan
The purpose of this study was to evaluate patient-reported morbidity of implanted fiducial markers used for image guidance in prostate radiotherapy. Three fiducial markers were implanted under transrectal ultrasound guidance to 177 patients who were referred to our department for definitive radiotherapy between June 2005 and January 2008. No local anaesthesia was administered. Patients were asked to complete a questionnaire about the possible side effects of this invasive procedure. 135 patients completed the questionnaire at a median of 57 weeks after the procedure. Pain during the procedure was assessed with the Wong-Baker Faces Pain Rating Scale. Patients were also asked to compare the pain with the diagnostic biopsy. Although haematuria, rectal bleeding and fever were reported by 15%, 4% and 2% of the 135 patients, respectively, no major toxicity necessitating any intervention was observed. The mean pain score reported by the patients was 1.7 (range, 0-5). 87% of patients reported less (or comparable) pain than the diagnostic biopsy. In conclusion, implantation of fiducial markers for image guidance in prostate radiotherapy is a safe and well-tolerated procedure.

29 May 2010 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
TETülay Ercan
Tülay Ercan
ŞIŞefik İğDem
Şefik İğDem
Gül AlçoGül Alço
Gül Alço
FZFunda Zengin
Funda Zengin
SASelin Atilla
Selin Atilla
SOSait Okkan
Sait Okkan